|
DNAJC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63340000003398E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58234999999562E-05 |
| Normal-vs-Stage2 |
7.233600E-02 |
| Normal-vs-Stage3 |
9.173000E-04 |
| Normal-vs-Stage4 |
3.27330000005066E-06 |
| Stage1-vs-Stage2 |
7.071800E-01 |
| Stage1-vs-Stage3 |
8.263600E-01 |
| Stage1-vs-Stage4 |
8.110400E-02 |
| Stage2-vs-Stage3 |
6.162800E-01 |
| Stage2-vs-Stage4 |
1.426830E-01 |
| Stage3-vs-Stage4 |
2.571800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66520000000059E-06 |
| Normal-vs-AfricanAmerican |
4.768300E-04 |
| Normal-vs-Asian |
9.738100E-03 |
| Caucasian-vs-AfricanAmerican |
9.447800E-01 |
| Caucasian-vs-Asian |
8.128800E-01 |
| AfricanAmerican-vs-Asian |
7.973400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60500000459629E-08 |
| Normal-vs-Female |
2.108200E-01 |
| Male-vs-Female |
2.818100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.986700E-04 |
| Normal-vs-Extreme_Weight |
1.60999999998523E-06 |
| Normal-vs-Obese |
4.895900E-03 |
| Normal-vs-Extreme_Obese |
1.864330E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.314600E-01 |
| Normal_Weight-vs-Obese |
2.867400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.110600E-01 |
| Extreme_Weight-vs-Obese |
1.665570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.227400E-01 |
| Obese-vs-Extreme_Obese |
3.157800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.8750999999968E-05 |
| Normal-vs-Age(41-60Yrs) |
8.822900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.58189999777525E-08 |
| Normal-vs-Age(81-100Yrs) |
3.61960000000439E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.756100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.308800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.203000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.823400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.090960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.385800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.89090000002734E-07 |
| Normal-VS-Type2 PRCC |
5.84909999999939E-05 |
| Normal-VS-KIRP CIMP |
8.15929999999909E-05 |
| Normal-VS-Unclassified PRCC |
3.983600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.410000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.951800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.000200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.177400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.058980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.038300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10090000005059E-06 |
| Normal-vs-N1 |
1.075790E-03 |
| Normal-vs-N2 |
3.407900E-02 |
| N0-vs-N1 |
8.601800E-01 |
| N0-vs-N2 |
7.846400E-01 |
| N1-vs-N2 |
8.675800E-01 |
|
|
